- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01494116
Pediatric Fast Fluid Randomized Controlled Trial
Factors Affecting Pediatric Isotonic Fluid Resuscitation Efficiency: Impact of Syringe Size
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Surviving Sepsis Guideline for the resuscitation of pediatric septic shock indicates that up to 60 mL/kg of isotonic saline should be administered within the first 15 minutes of resuscitation. There are practical challenges to achieving these benchmarks. Syringes are often used to perform manual fluid resuscitation as they are generally available and health care providers are typically comfortable using them. Health care providers have been observed to have different preferences regarding the syringe size used to perform manual fluid resuscitation. Larger syringes e.g. 60 mL-size requires more force to depress the syringe plunger, due to a larger crosssectional area, but fewer syringes are needed to administer a given volume. Fewer syringes results in less time spent connecting and disconnecting syringes, which contributes to total fluid resuscitation time using this technique.
Consenting participants will be randomly assigned (by an independent Randomization Coordinator) to one of four syringe size groups (10 mL, 20 mL, 30 mL, 60 mL sizes). The allocation sequence is therefore concealed. After undergoing a standardization procedure, each participant will be instructed to administer 900 mL of 0.9% normal saline using pre-filled provided syringes by manual push as rapidly as possible using the disconnect-reconnect method. Participants will be advised to consider that they are in a situation where they are resuscitating a 15 kg child (represented by the model) in decompensated shock. Syringes for each 300 mL (20 mL/kg) aliquot will be colour-coded for identification purposes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N3Z5
- Hamilton Health Sciences, McMaster Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Consenting health care staff and health care students capable of performing manual syringe bolus fluid administration
Exclusion Criteria:
- Non-English speaking individuals
- Any condition that would impact upon the individual's ability to perform manual fluid resuscitation e.g. limited hand strength or dexterity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: 10 mL syringe size
|
The intervention consists of the administration of 900 mL of Normal Saline to the model using the "Disconnection- Reconnection" method of manual fluid resuscitation.
All syringes (syringe size based on study arm) will be prepared by research staff following subject randomization.
Each subject will take the prepared syringes, and sequentially administer them to the model by 1. Selecting and connecting a fluid-filled syringe to the catheter extension set to permit fluid administration 2. Manually administering the fluid to the model by depressing the syringe plunger 3. Disconnecting and discarding the empty syringe 4. Repeating steps 1-3 as fast as possible until all 900 mL has been administered.
Other Names:
|
|
EXPERIMENTAL: 20 mL syringe size
|
The intervention consists of the administration of 900 mL of Normal Saline to the model using the "Disconnection- Reconnection" method of manual fluid resuscitation.
All syringes (syringe size based on study arm) will be prepared by research staff following subject randomization.
Each subject will take the prepared syringes, and sequentially administer them to the model by 1. Selecting and connecting a fluid-filled syringe to the catheter extension set to permit fluid administration 2. Manually administering the fluid to the model by depressing the syringe plunger 3. Disconnecting and discarding the empty syringe 4. Repeating steps 1-3 as fast as possible until all 900 mL has been administered.
Other Names:
|
|
EXPERIMENTAL: 30 mL syringe size
|
The intervention consists of the administration of 900 mL of Normal Saline to the model using the "Disconnection- Reconnection" method of manual fluid resuscitation.
All syringes (syringe size based on study arm) will be prepared by research staff following subject randomization.
Each subject will take the prepared syringes, and sequentially administer them to the model by 1. Selecting and connecting a fluid-filled syringe to the catheter extension set to permit fluid administration 2. Manually administering the fluid to the model by depressing the syringe plunger 3. Disconnecting and discarding the empty syringe 4. Repeating steps 1-3 as fast as possible until all 900 mL has been administered.
Other Names:
|
|
EXPERIMENTAL: 60 mL syringe size
|
The intervention consists of the administration of 900 mL of Normal Saline to the model using the "Disconnection- Reconnection" method of manual fluid resuscitation.
All syringes (syringe size based on study arm) will be prepared by research staff following subject randomization.
Each subject will take the prepared syringes, and sequentially administer them to the model by 1. Selecting and connecting a fluid-filled syringe to the catheter extension set to permit fluid administration 2. Manually administering the fluid to the model by depressing the syringe plunger 3. Disconnecting and discarding the empty syringe 4. Repeating steps 1-3 as fast as possible until all 900 mL has been administered.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Intervention Time
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Subject is randomized and the intervention is performed the same day.
Start Intervention Time (time zero): Subject begins administering the intervention; End Intervention Time: Subject has completed the intervention (900 mL of Saline has been administered); Total Intervention Time = End Intervention Time - Start Intervention Time.
All testing is being video recorded.
A blinded outcome assessor will review the video tapes and based upon clear, a priori defined, definitions will determine the Start Intervention Time and the End Intervention Time for each subject.
|
From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to administer each of three sequential 300 mL fluid boluses
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Bolus 1 Time = Time at 300 mL administered MINUS Start Intervention Time; Bolus 2 Time = Time at 600 mL administered MINUS Time at 300 mL administered; Bolus 3 Time = Time at 900 mL administered (End Intervention Time) MINUS Time at 600 mL administered. Syringes are marked with coloured tape to facilitate identification according to Bolus number (Bolus 1 - Green; Bolus 2 - Yellow; Bolus 3 - Red). |
From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
|
Amount of normal saline actually administered to the model
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
The normal saline administered to the model travels via conduit tubing in a dependent fashion to a graduated cylinder where it is collected for measurement upon completion of testing for each subject.
|
From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
|
The proportion of subjects in each group that dislodge the IV catheter during testing.
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Any IV catheter dislodgement episodes will be recorded.
The catheter used in this model is a 1.00 inch, 22-gauge, Insyte Autoguard IV catheter.
The proximal end (hub) of the IV catheter is transfixed to the hand of the mannequin in typical clinical fashion, while the distal end is located within conduit tubing that leads to a 1 litre graduated cylinder.
Connected to the hub of the IV catheter is a 7 inch long IV Catheter Extension Set.
|
From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
|
Self-reported comfort of health care providers while performing the study intervention
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Based on responses to questionnaire that subjects are asked to complete following completion of the intervention
|
From Date of Subject Randomization until Date Intervention Completed (Day 1)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Melissa J Parker, MD, MSc, McMaster Children's Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 11-272
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fluid Resuscitation
-
Hospital NordRecruitingFluid Responsiveness Predictability | Fluid ResuscitationFrance
-
University of MonastirEnrolling by invitationFluid Therapy | Fluid Resuscitation | Fluid ReponsivenessTunisia
-
Beni-Suef UniversityUnknownFluid Resuscitation Monitoring Non-invasivelyEgypt
-
The George Institute for Global Health, AustraliaCompletedCritical Care, Fluid ResuscitationAustralia
-
Assiut UniversityNot yet recruitingFluid Resuscitation
-
Satu Mare County Emergency HospitalRecruitingFluid Resuscitation | Acute Pancreatitis (AP) | Acute Pancreatic Fluid CollectionRomania
-
McMaster Children's HospitalRegional Medical Associates of HamiltonCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Medical University of ViennaNot yet recruitingCardiac and Aortic Surgery | Venous Congestion | Fluid Resuscitation | Cardiac Anaesthesia
-
Al-Azhar UniversityCompletedShock | Transthoracic Echocardiography | Electrical Cardiometry | Fluid ResuscitationEgypt
Clinical Trials on 900 mL of 0.9% Normal Saline
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated... and other collaboratorsRecruitingCritical Illness | Acute Kidney Injury | Hypotension | Renal Replacement TherapyCanada
-
Jeffrey Alan Klein, MDNot yet recruitingAnesthesia, Local | Injection Site Irritation | Injection Site Discomfort | Injection Site Bruising | Benzoic Acid Adverse ReactionUnited States
-
Azienda USL Reggio Emilia - IRCCSAzienda Sanitaria OspedalieraCompletedContrast Induced NephropathyItaly
-
Tri-Service General HospitalCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoWithdrawn
-
University of HaifaWestern Galilee Hospital-NahariyaRecruiting
-
Virginia Commonwealth UniversityUnited States Department of DefenseWithdrawn
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health...CompletedHemorrhagic Shock | Blunt Trauma | Penetrating WoundUnited States, Canada
-
The University of Texas Health Science Center at...National Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
-
Taipei Veterans General Hospital, TaiwanUnknown